Axisresearch
List of Categories
- Aerospace & Defense
- Agriculture
- Animal Nutrition & Wellness
- Automation
- Automotive
- Chemical & Materials
- Consumer Goods and Services
- Electronics
- Energy & Mining
- Financial Services & Investment Intelligence
- Food & Beverage
- Healthcare
- Heavy Industry
- Home & Property Improvement
- Information & Communications Technology
- Investment Opportunities
- Manufacturing
- NEO
- Others
- Packaging
- Retail
- Technology & Media
- Transportation & Logistics
Sorted by Name
Publishers
Countries
Contact Lenses Market – Growth, Trends, and Forecasts (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 10-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 10-06-2019
Market Overview
The growth of the global contact lens market is due to the increasing prevalence of optical disorders, increasing tendency to enhance aesthetics, and increasing disposable incomes. As of 2017, according to WHO estimates, age-related macular degeneration (AMD) ranked third among the global causes of visual impairment, with the prevalence of blindness being 8.7%. It is the primary cause of visual deficiency in industrialized countries. Additionally, an emerging important cause of visual impairment in the developed regions of the world is uncorrected refractive errors.
According to the 2010 assessment by WHO, cataract was responsible for 51% of world blindness, which represented approximately 20 million people. Due to increasing life expectancy, particularly in the developed region of the world, the number of people with cataract is anticipated to grow. Consequently, cataract is an important cause of low vision in both developed and developing countries. A higher disposable income translates to greater spending in all areas of personal expense. The increasing disposable income in the developed countries is prompting the purchase of low-priority commodities, specifically those pertaining to cosmetics. Consequently, increasing disposable income in developed countries is a driver for the growth of the global contact lens market.
Scope of the Report
Contact lenses not only serve the need to alleviate the use of hard-to-manage and bulky spectacles, but also provide the added benefit of enhancing one’s aesthetic appeal. The increasing innovations in the production of contact lenses during the past decade have led to the use of various materials for producing lenses that serve multiple purposes. Contact lenses are also used to treat common eye disorders, such as myopia, hypermetropia, presbyopia, astigmatism, and glaucoma.
Key Market Trends
Rigid Gas Permeable Contact Lenses Segment is Expected to Exhibit the Fastest Growth Rate over the Forecast Period
A rigid gas permeable lens is also known as RGP lens or GP lens. It is a rigid contact lens made of oxygen-permeable polymers. They are porous and allow the oxygen to pass through them. These rigid lenses are able to replace the natural shape of the cornea with a new refracting surface. Since their introduction, these lenses have essentially replaced non-porous polymethyl methacrylate (PMMA) contact lenses.
These lenses often provide sharper vision than soft and silicone hydrogel contacts, especially if someone has astigmatism. It usually takes some time for the eyes to adjust to these lenses, but after this initial adaptation period, most people find that these lenses are as comfortable as hydrogel lenses.
Although these lenses have dominated the market earlier, they have lost significant value in the past two decades with the advancement of soft lenses in the market. Hence, they are much more cost effective and generally last long when taken care of properly, as long as one does not require a prescription change. This may be a driving factor for the forecast period.
North America Captured the Largest Market Share and is Expected to Retain its Dominance
North America holds the largest share in the global contact lenses market with the United States being the largest contributor to its revenue. The United States is one of the major countries in the contact lens market, due to the healthcare facilities available in the country and high healthcare conditions. Factors, such as the presence of geriatric population and the prevalence of eye diseases and injuries, in terms of contact lens market, are primarily fueling the growth.
The National Eye Institute has estimated that over 2.9 million US residents were detected with low vision in 2014. The number is projected to increase further and is expected to reach around 5 million by the year 2030. In addition to this, as per a report by the US Centre of Disease Control and Prevention, about 40.9 million wearers of contact lenses were aged 18 or older, accounting for about 16.7% of the adult population in the United States in 2015. This increase is anticipated to accelerate the growth of contact lenses wearers in the country over the forecast period.
Competitive Landscape
The global contact lenses market is highly competitive and consists of several major players. The presence of major market players, such as Staar Surgical, Novartis AG, Bausch Health Companies Inc., Zeiss Group, and The Cooper Companies are, in turn, increasing the overall competitive rivalry of the market. With moderate sustainable competitive advantage through innovative products and low competition between online and offline companies, moderate competitive rivalry is observed in this market.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Introduction to Market Drivers and Restraints
4.3 Market Drivers
4.3.1 Increasing Prevalence of Optical Disorders
4.3.2 Increasing Tendency to Enhance Aesthetics
4.3.3 Increasing Disposable Incomes
4.4 Market Restraints
4.4.1 Availability of Alternative Techniques
4.4.2 Complications Associated with Lens
4.5 Industry Attractiveness Porter’s Fives Force Analysis
4.5.1 Threat of New Entrants
4.5.2 Bargaining Power of Buyers/Consumers
4.5.3 Bargaining Power of Suppliers
4.5.4 Threat of Substitute Products
4.5.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Soft Contact Lenses
5.1.2 Hybrid Contact Lenses
5.1.3 Rigid Gas Permeable Contact Lenses
5.1.4 Other Product Types
5.2 By Usage
5.2.1 Corrective Contact Lenses
5.2.2 Therapeutic Contact Lenses
5.2.3 Cosmetic Contact Lenses
5.2.4 Prosthetic Contact Lenses
5.3 By Modality
5.3.1 Conventional
5.3.2 Disposable
5.3.2.1 Daily
5.3.2.2 Monthly
5.3.2.3 Other Disposable Modalities
5.4 By Design
5.4.1 Spherical
5.4.2 Toric
5.4.3 Multifocal
5.4.4 Other Designs
5.5 By Distribution Channel
5.5.1 Spectacle Stores
5.5.2 Online Store
5.5.3 Other Distribution Channels
5.6 Geography
5.6.1 North America
5.6.1.1 United States
5.6.1.2 Canada
5.6.1.3 Mexico
5.6.2 Europe
5.6.2.1 United Kingdom
5.6.2.2 Germany
5.6.2.3 France
5.6.2.4 Italy
5.6.2.5 Spain
5.6.2.6 Rest of Europe
5.6.3 Asia-Pacific
5.6.3.1 China
5.6.3.2 Japan
5.6.3.3 India
5.6.3.4 Australia
5.6.3.5 South Korea
5.6.3.6 Rest of Asia-Pacific
5.6.4 Middle East & Africa
5.6.4.1 GCC
5.6.4.2 South Africa
5.6.4.3 Rest of Middle East & Africa
5.6.5 South America
5.6.5.1 Brazil
5.6.5.2 Argentina
5.6.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Staar Surgical
6.1.2 Novartis AG
6.1.3 Bausch Health Companies Inc.
6.1.4 Zeiss Group
6.1.5 The Cooper Companies
6.1.6 Essilor International SA
6.1.7 Hoya Corporation
6.1.8 Haohai Biological Technology
6.1.9 Johnson & Johnson Vision Care Inc..
6.1.10 SynergEyes Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
Soft Contact Lenses
Hybrid Contact Lenses
Rigid Gas Permeable Contact Lenses
Other Product Types
By Usage
Corrective Contact Lenses
Therapeutic Contact Lenses
Cosmetic Contact Lenses
Prosthetic Contact Lenses
By Modality
Conventional
Disposable
Daily
Monthly
Other Disposable Modalities
By Design
Spherical
Toric
Multifocal
Other Designs
By Distribution Channel
Spectacle Stores
Online Store
Other Distribution Channels
Geography
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Continuous Glucose Monitoring (CGM) Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 75 pages | Published: 12-06-2019 |
- Healthcare
- Mordor Intelligence
- 75 pages
- Published: 12-06-2019
Market Overview
As per WHO data, approximately half of all mortality can be associated with high blood glucose levels, which occur before the age of 70 years.
WHO also expects diabetes to be the seventh-leading cause of mortality by 2030. For patients reliant on insulin pumps or daily insulin injections, the CGM establishes itself to be an instrumental tool, which helps in the enhancement of glycemic balance without increasing the danger of fatal hypoglycemia.
As studied in several clinical trials, diabetic patients with Type 1 diabetes mellitus (T1DM) have been shown to have better glycemic control, in comparison to when glucometer is used for routine self-monitoring blood glucose.
The trend follows in children, as well as those who use a CGM on a regular basis. The results in these children show better-glycosylated hemoglobin (HbA1c) levels without an amplified frequency of hypoglycemia.
The current CGM models approved administer glucose oxidase-based electrochemical subcutaneous sensors for the detection of glucose levels in the interstitial fluid.
Scope of the Report
By the component, the market has been segmented into sensors and receivers.
CGM devices can either retrospectively display the trends in the levels of blood glucose by downloading the data or give a real-time picture of glucose levels through receiver displays.
Most of the real-time CGMs can offer an alert to patients, parents, or caregivers during actual or pending glycemic visits, to facilitate timely management of blood glucose.
Key Market Trends
Complete Information about Blood Glucose Patterns and Trends
CGMs are used to provide a further descriptive representation of blood glucose patterns and tendencies than what can be achieved by conventional routine checking of glucose levels at set intervals.
The current CGM devices can either retrospectively display the trends in the levels of blood glucose by downloading the data or give a real-time picture of glucose levels through receiver displays.
Most of the real-time CGMs have the capability to offer an alert to patients, parents, or caregivers during actual or pending glycemic visits, in order to facilitate timely management of blood glucose.
This factor, along with the fact that CGM devices are becoming cheaper with the advent of new technologies, like cell phone integration, is likely to drive the steady growth of the CGM market during the forecast period.
North America will Maintain Dominance in the Market
In North America, the United States accounted for close to 97% of the market value in 2017. By 2019, the continuous glucose monitoring market in the United States is expected to be valued at USD 1175.5 million.
The United States also accounts for the highest CAGR of 13.2%. It is imperative that the CGM devices be used alongside insulin pumps. As the trends show a higher number of diabetic patients using insulin pumps for diabetes management, it can be predicted that the number of units of CGM devices sold will also follow.
Competitive Landscape
A major share of the market is held by CGM manufacturers that are concomitant with strategy-based M&A operations and are constantly entering new markets to generate new revenue streams and to boost existing ones.
These measures taken by the market players will ensure a competitive market place, therefore, forcing the companies to experiment with more new technologies, in order to ensure uniqueness in their products.
Also, one of the implications of the competition in the market is that it will ensure a constant decrease in the average selling price of the CGM units produced.
For instance, in December 2017, Abbott’s new FreeStyle Libre Flash Glucose Monitoring System was approved, which is the first continuous blood sugar monitor for diabetics that does not need backup finger prick tests, Abbott has also priced the new device substantially lower than its competitors, which will help the company to strengthen its position in the CGM market during the forecast period.
In January 2016, Ypsomed AG appointed TD Pharmaceutical (Tonghua Dongbau Pharmaceutical) as the exclusive distributor for its range of products in China; hence, reinforcing their pre-existing partnership.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Drivers
4.3 Restraints
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Consumers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products and Services
4.4.5 Intensity of Competitive Rivalry
5 Market Segmentation
5.1 Continuous Blood Glucose Monitoring
5.1.1 By Component (Value and Volume, 2012 – 2024)
5.1.1.1 Sensors
5.1.1.2 Receivers
5.2 Geography
5.2.1 North America
5.2.1.1 United States (Value and Volume, 2012 – 2024)
5.2.1.2 Canada (Value and Volume, 2012 – 2024)
5.2.1.3 Rest of North America (Value and Volume, 2012 – 2024)
5.2.2 Europe
5.2.2.1 France (Value and Volume, 2012 – 2024)
5.2.2.2 Germany (Value and Volume, 2012 – 2024)
5.2.2.3 Italy (Value and Volume, 2012 – 2024)
5.2.2.4 Spain (Value and Volume, 2012 – 2024)
5.2.2.5 United Kingdom (Value and Volume, 2012 – 2024)
5.2.2.6 Russia (Value and Volume, 2012 – 2024)
5.2.2.7 Rest of Europe (Value and Volume, 2012 – 2024)
5.2.3 Latin America
5.2.3.1 Mexico (Value and Volume, 2012 – 2024)
5.2.3.2 Brazil (Value and Volume, 2012 – 2024)
5.2.3.3 Rest of Latin America (Value and Volume, 2012 – 2024)
5.2.4 Asia-Pacific
5.2.4.1 Japan (Value and Volume, 2012 – 2024)
5.2.4.2 South Korea (Value and Volume, 2012 – 2024)
5.2.4.3 China (Value and Volume, 2012 – 2024)
5.2.4.4 India (Value and Volume, 2012 – 2024)
5.2.4.5 Australia (Value and Volume, 2012 – 2024)
5.2.4.6 Vietnam (Value and Volume, 2012 – 2024)
5.2.4.7 Malaysia (Value and Volume, 2012 – 2024)
5.2.4.8 Indonesia (Value and Volume, 2012 – 2024)
5.2.4.9 Philippines (Value and Volume, 2012 – 2024)
5.2.4.10 Thailand (Value and Volume, 2012 – 2024)
5.2.4.11 Rest of Asia-Pacific (Value and Volume, 2012 – 2024)
5.2.5 Middle East & Africa
5.2.5.1 Saudi Arabia (Value and Volume, 2012 – 2024)
5.2.5.2 Iran (Value and Volume, 2012 – 2024)
5.2.5.3 Egypt (Value and Volume, 2012 – 2024)
5.2.5.4 Oman (Value and Volume, 2012 – 2024)
5.2.5.5 South Africa (Value and Volume, 2012 – 2024)
5.2.5.6 Rest of Middle & Africa (Value and Volume, 2012 – 2024)
6 MARKET INDICATORS
6.1 Type 1 Diabetes Population (2012-2024)
6.2 Type 2 Diabetes Population (2012-2024)
7 COMPETITIVE LANDSCAPE
7.1 COMPANY PROFILES
7.1.1 Abbott Diabetes Care
7.1.2 Dexcom
7.1.3 Medtronic
7.2 COMPANY SHARE ANALYSIS
7.2.1 Abbott Diabetes Care
7.2.2 Dexcom
7.2.3 Medtronic
7.2.4 Others
8 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
Continuous Blood Glucose Monitoring
By Component (Value and Volume, 2012 – 2024)
Sensors
Receivers
Geography
North America
United States (Value and Volume, 2012 – 2024)
Canada (Value and Volume, 2012 – 2024)
Rest of North America (Value and Volume, 2012 – 2024)
Europe
France (Value and Volume, 2012 – 2024)
Germany (Value and Volume, 2012 – 2024)
Italy (Value and Volume, 2012 – 2024)
Spain (Value and Volume, 2012 – 2024)
United Kingdom (Value and Volume, 2012 – 2024)
Russia (Value and Volume, 2012 – 2024)
Rest of Europe (Value and Volume, 2012 – 2024)
Latin America
Mexico (Value and Volume, 2012 – 2024)
Brazil (Value and Volume, 2012 – 2024)
Rest of Latin America (Value and Volume, 2012 – 2024)
Asia-Pacific
Japan (Value and Volume, 2012 – 2024)
South Korea (Value and Volume, 2012 – 2024)
China (Value and Volume, 2012 – 2024)
India (Value and Volume, 2012 – 2024)
Australia (Value and Volume, 2012 – 2024)
Vietnam (Value and Volume, 2012 – 2024)
Malaysia (Value and Volume, 2012 – 2024)
Indonesia (Value and Volume, 2012 – 2024)
Philippines (Value and Volume, 2012 – 2024)
Thailand (Value and Volume, 2012 – 2024)
Rest of Asia-Pacific (Value and Volume, 2012 – 2024)
Middle East & Africa
Saudi Arabia (Value and Volume, 2012 – 2024)
Iran (Value and Volume, 2012 – 2024)
Egypt (Value and Volume, 2012 – 2024)
Oman (Value and Volume, 2012 – 2024)
South Africa (Value and Volume, 2012 – 2024)
Rest of Middle & Africa (Value and Volume, 2012 – 2024)
Contraceptive Drugs and Devices Market – Segmented by Contraceptive Method, by Mode of Delivery, by Type of Device, by Gender and Geography – Growth, Trends and Forecasts (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| Unknown | Published: 25-06-2019 |
- Healthcare
- Mordor Intelligence
- pages
- Published: 25-06-2019
The major factors propelling the growth of the contraceptive drugs and devices market includes the increasing incidence of the STD, an increasing rate of unintended pregnancies, and the rise in government initiatives.
Scope of the Report
As per the scope of the report, contraceptive drugs and devices are the drugs and devices used for birth control. Contraception is more commonly known as fertility and birth control is described as the method used to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum. The proper use of contraceptives, such as female and male condoms also prevents the spread of sexually transmitted diseases.
Key Market Trends
Oral Contraceptives is Estimated to have Largest Share in the Segmentation by Drugs over the Forecast Period
Oral contraceptive pills are seen as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. These are easily marketed across large regions by global companies and thus easily consumed by a large section of the population, globally. These factors are expected to contribute to the growth of the market over the forecast period. The other forms of contraceptive drugs, such as topical and injectable contraceptives have also witnessed a strong market demand.
North America has been Reported with the Largest Share and Consistent Growth over the Forecast Period.
North America is expected to register a high growth, owing to the presence of sophisticated healthcare infrastructure, the high adoption rate of contraceptive drugs, and the rising number of government initiatives that help in increasing the overall market. A large section of the women population represents the reproductive age in the United States as well as Canada. With that, a significant size of the population is at risk of unintended pregnancy, as their partners do not use a contraceptive method, correctly and consistently. The awareness regarding these products is also high with considerable support being provided by several hospitals to control the patients affected by its misuse. Moreover, the distribution channel of several companies is well established across the United States and Canada, which overall drives the market and contributes to the largest share, over the forecast period.
Competitive Landscape
Over the forecast period, most of the domestic and international players are found focusing on the emerging market and these countries are growing rapidly in the contraceptive drugs and devices market.
Table of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of the STDs
4.2.2 Increasing Rate of Unintended Pregnancies
4.2.3 Rise in Government Initiatives
4.3 Market Restraints
4.3.1 High Cost of Devices and Treatment
4.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products
5.1.1 By Drugs
5.1.1.1 Oral Contraceptives
5.1.1.2 Topical Contraceptives
5.1.1.3 Contraceptive Injectable
5.1.2 By Device
5.1.2.1 Condoms
5.1.2.2 Diaphragms
5.1.2.3 Cervical Caps
5.1.2.4 Sponges
5.1.2.5 Vaginal Rings
5.1.2.6 IUD
5.1.2.7 Other Devices
5.2 By Gender
5.2.1 Male
5.2.2 Female
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Pfizer Inc.
6.1.3 Merck & Co. Inc.
6.1.4 Teva Pharmaceuticals Ltd
6.1.5 Agile Therapeutics
6.1.6 Allergan PLC
6.1.7 Ani Pharmaceuticals Inc.
6.1.8 Church & Dwight Co. Inc.
6.1.9 Fuji Latex Co. Ltd
6.1.10 Johnson & Johnson Ltd
*List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
MARKET SEGMENTATION
By Products
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Other Devices
By Gender
Male
Female
Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
CONTRACEPTIVE DRUGS AND DEVICES MARKET- GROWTH, TRENDS, AND FORECAST (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 111 pages | Published: 01-03-2019 |
- Healthcare
- Mordor Intelligence
- 111 pages
- Published: 01-03-2019
Sample
The global interactive whiteboard market size was valued at USD 1.51 billion in 2018 and is anticipated to expand at a CAGR of 6.8 % from 2019 to 2025. Rising adoption of advanced learning methods is one of the factors positively affecting the IWB usage. These boards provide an adaptive, engaging, and user-friendly learning experience and are therefore gaining popularity among various sectors, such as government, corporate, and education. Digital learning has transformed conventional classroom teaching.
The emergence of virtual classrooms and e-learning courses has resulted in an increased demand for IWBs. The e-learning industry has witnessed a significant growth over the last decade due to the rapid evolution of digitization, communication, and other technological advancements that are cost-effective and are easily available for a wider audience. Furthermore, significant investments in Information and Learning Technology (ILT) infrastructure in colleges, development of digital content and mobile learning applications, and national training initiatives have transformed the traditional chalk and board learning and teaching methods.
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of the STDs
4.2.2 Increasing Rate of Unintended Pregnancies
4.2.3 Rise in Government Initiatives
4.3 Market Restraints
4.3.1 High Cost of Devices and Treatment
4.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products
5.1.1 By Drugs
5.1.1.1 Oral Contraceptives
5.1.1.2 Topical Contraceptives
5.1.1.3 Contraceptive Injectable
5.1.2 By Device
5.1.2.1 Condoms
5.1.2.2 Diaphragms
5.1.2.3 Cervical Caps
5.1.2.4 Sponges
5.1.2.5 Vaginal Rings
5.1.2.6 IUD
5.1.2.7 Others
5.2 By Gender
5.2.1 Male
5.2.2 Female
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer Healthcare
6.1.2 Pfizer
6.1.3 Merck & Co.
6.1.4 Teva Pharmaceuticals Ltd
6.1.5 Agile Therapeutics
6.1.6 Allergan PLC
6.1.7 Ani Pharmaceuticals Inc.
6.1.8 Church & Dwight Co. Inc.
6.1.9 Fuji Latex Co. Ltd
6.1.10 Johnson & Johnson Ltd
*List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Market Segmentation
- Interactive Whiteboards Technology Outlook (Revenue, USD Million, 2014 – 2025)
- Infrared
- Resistive Membrane
- Electromagnetic Pen
- Capacitive
- Others
- Interactive Whiteboards Form Factor Outlook (Revenue, USD Million, 2014 – 2025)
- Fixed
- Portable
- Interactive Whiteboards Projection Technique Outlook (Revenue, USD Million, 2014 – 2025)
- Front Projection
- Rear Projection
- Interactive Whiteboards Application Outlook (Revenue, USD Million, 2014 – 2025)
- Education
- Corporate
- Commercial
- Others
Why choose us
-
24/5 Research supportGet your queries resolved from an industry expert.
-
Custom research serviceDesign an exclusive study to serve your research needs.
-
Quality assuranceA testimonial for service in the form of BBB “A” Accreditation.
-
Information securityYour personal and confidential information is safe and secure.
Coronary Stent Market- Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 118 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 118 pages
- Published: 07-06-2019
Market Overview
The major factors found propelling the growth of the market include the increasing prevalence of coronary artery diseases (CADs), rising the geriatric population, and the technological advancements in coronary stents.
The prevalence of coronary artery disease (CAD) has increased in the past three decades in the low- and middle-income countries, including India. Coronary artery disease is responsible for 20% of the total deaths in India. Thus the burden of CAD has increased and has boosted the usage of coronary stents, thus helping in driving the market growth. In addition, the increasing geriatric population has also increased the demand for coronary stents that is expected to rise over the forecast period.
There has also been a high demand for minimally invasive surgical procedures that is likely to significantly drive the coronary stent market. Thus, there has been a reduction in post-operative trauma and complications with the use of a minimally invasive surgical procedure, which is the major growth driver. Reduced hospital stays and lesser healing time are the other advantages associated with the use of advanced and miniaturized coronary stents.
Scope of the Report
As per the scope of the report, coronary stents are small elastic tubes used for the treatment of narrowed and blocked coronary arteries in patients with coronary artery disease (CAD). These reduce the symptoms of chest pain (angina) and aid in the treatment of a heart attack. These types of stents are also called as heart stents or cardiac stents. They comprise metal mesh and are implanted in constricted coronary arteries during a technique known as percutaneous coronary intervention (PCI) or angioplasty.
Key Market Trends
Drug-eluting Stent is the Largest Segment by Product Type that is Expected to Grow during the Forecast Period
The drug-eluting stent segment has accounted for the largest revenue, as it can be used for the treatment of a large number of disorders, such as diabetes, renal disease, percutaneous coronary intervention, and ST-segment elevation myocardial infarction (STEMI). There are also various technological advances seen in the drug-eluting stent segment that may witness tremendous growth.
North America Experienced the Largest Growth and is Expected to Follow the Same Trend Over the Forecast Period
North America holds the largest market share for coronary stents, due to the dominance of the top companies present in the global market. There is also an increase in the ageing population, an increase in the prevalence of heart diseases, and technological advancements found in the region. In addition, other factors, such as good reimbursement scenario, have been driving the North American coronary stent market.
Competitive Landscape
The major companies have adopted strategies like mergers and acquisitions and strategic alliances to gain a competitive advantage in the market. Additionally, companies are also more focused on the development of technologically advanced products, which deliver greater accuracy and efficiency.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Coronary Artery Diseases (CADs)
4.2.2 Rising of the Geriatric Population
4.2.3 Technological Advancements in Coronary Stents
4.3 Market Restraints
4.3.1 High Product Recalls
4.3.2 Stringent Approval Process for Stents
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Drug Eluting Stent
5.1.2 Bare Metal Coronary Stent
5.1.3 Bioabsorbable Stent
5.2 By Biomaterial
5.2.1 Metallic Biomaterial
5.2.2 Polymeric Biomaterial
5.2.3 Natural Biomaterial
5.3 By End User
5.3.1 Hospital
5.3.2 Ambulatory Surgical Centre
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 B. Braun Medical Inc.
6.1.3 Biosensors International Group, Ltd.
6.1.4 BIOTRONIK SE & Co. KG
6.1.5 Boston Scientific Corporation
6.1.6 IRIDEX Corporation
6.1.7 Medtronic PLC
6.1.8 Terumo Corporation
6.1.9 Translumina GmbH
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
MARKET SEGMENTATION
By Product Type
Drug Eluting Stent
Bare Metal Coronary Stent
Bioabsorbable Stent
By Biomaterial
Metallic Biomaterial
Polymeric Biomaterial
Natural Biomaterial
By End User
Hospital
Ambulatory Surgical Centre
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America
Defibrillator Market – Growth, Trends, and Forecast (2019 – 2024)
| Healthcare | Published by: Mordor Intelligence | Market: |
| 110 pages | Published: 07-06-2019 |
- Healthcare
- Mordor Intelligence
- 110 pages
- Published: 07-06-2019
Market Overview
The growth of the defibrillator market can be attributed to factors such as technological advancements in the field of defibrillators and training and awareness programs for defibrillators. According to the American Heart Association’s research program, cardiovascular diseases are listed as the primary cause of deaths, and accounted for nearly 836,546 deaths in the United States. The deaths related to cardiovascular diseases are higher when compared to deaths related to all forms of cancer and chronic lower respiratory diseases combined. As per the American Heart Association, cardiovascular disease is the leading cause of death, globally, accounting for more than 17.9 million deaths per year in 2015, a number that is expected to grow to more than 23.6 million by 2030. Hence, the increase in prevalence of cardiovascular diseases is expected to drive the market growth.
Scope of the Report
Defibrillator is a life-saving device that helps deliver a therapeutic shock to a patient’s heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. In the United States, approximately 300,000 out-of-hospital cardiac arrests occur each year. Supportive government policies in developed countries may help increase the availability and access of defibrillators, which will likely further boost the market growth over the forecast period.
Key Market Trends
Implantable Cardioverter Defibrillator(ICD) Spearheaded the Defibrillator Market
The implantable cardioverter defibrillator (ICD) segment accounted for the largest share in the global market. The ICDs are of three major types, namely transvenous ICDs, subcutaneous ICDs, and CRT with pacemaker and ICD function. The transvenous and subcutaneos ICDs are expected to exhibit the fastest growth rate over the forecast period, owing to the rising technological advancements, increasing R&D, and benefits associated with these ICDs. The overall ICD segment contributes for the largest market share, owing to the rising integration of multiple technological capabilities in a single device, such as defibrillators and pacemakers. In addition, the efficacy of these devices to manage arhythmias for a prolonged period is expected to drive the segment growth over the forecast period.
North America Dominated the Global Defibrillator Market
Cardiovascular diseases, listed as the underlying cause of death, account for nearly 836,546 deaths (about 1 of every 3 deaths) in the United States. Thus, the increasing prevalence of cardiovascular diseases in the region is expected to drive the growth of this market over the forecast period. In 2017, the Department of Health and Human Services (HHS), along with a number of public and private partners, launched the Million Hearts initiative that aims to prevent one million heart attacks and strokes. All the aforementioned factors are expected to boost the market growth.
Competitive Landscape
The major players operating in the defibrillators market are Boston Scientific Corporation, Koninklijke Philips NV., Medtronic, Nihon Kohden Corporation, and Abbott Laboratories. The key strategies adopted by the major market players are acquisitions and mergers, new product developments, geographical expansions, and enhanced marketing strategies.
Reasons to Purchase this report:
– The market estimate (ME) sheet in Excel format
– Report customization as per the client’s requirements
– 3 months of analyst support
1. Introduction
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. Research Methodology
3. Executive Summary
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Cardiovascular Diseases
4.2.2 Technological Advancements in the Field of Defibrillators
4.2.3 Training and Awareness Programs about Defibrillators
4.3 Market Restraints
4.3.1 High Costs of Defibrilators
4.3.2 Stringent Regulatory Framework
4.4 Industry Attractiveness Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. Market Segmentation
5.1 By Product
5.1.1 Implantable Cardioverter Defibrillator
5.1.1.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
5.1.1.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
5.1.1.3 CRT with Pacemaker and ICD Function (CRT-D)
5.1.2 External Defibrillator (ED)
5.1.2.1 Automated External Defibrillator (AEDs)
5.1.2.1.1 Semi-automated External Defibrillators
5.1.2.1.2 Fully-automated External Defibrillators
5.1.2.2 Manual External Defibrillator
5.1.2.3 Wearable Cardioverter Defibrillators (WCDs)
5.2 By End User
5.2.1 Hospitals
5.2.2 Emergency Care
5.2.3 Home Care
5.2.4 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 United Kingdom
5.3.2.2 Germany
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. Competitive Landscape
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Boston Scientific Corporation
6.1.3 Cardiac Science Corporation
6.1.4 Defibtech LLC
6.1.5 Koninklijke Philips NV
6.1.6 LivaNova PLC
6.1.7 Medtronic plc.
6.1.8 NIHON KOHDEN CORPORATION
6.1.9 Physio-Control Inc.
6.1.10 ZOLL Medical Corporation
7. Market Opportunities and Future Trends
Market Segmentation
- By Product
Implantable Cardioverter Defibrillator
Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
CRT with Pacemaker and ICD Function (CRT-D)
External Defibrillator (ED)
Automated External Defibrillator (AEDs)
Semi-automated External Defibrillators
Fully-automated External Defibrillators
Manual External Defibrillator
Wearable Cardioverter Defibrillators (WCDs)
By End User
Hospitals
Emergency Care
Home Care
Other End Users
Geography
North America
United States
Canada
Mexico - Europe
United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America